Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details 3)

v3.20.1
Shareholders' Deficit (Details 3) - Warrants [Member]
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Number of Warrants  
Balance Outstanding, Beginning | shares 2,050,000
Granted | shares 144,375
Cancelled | shares
Balance Outstanding, Ending | shares 2,194,375
Exercisable | shares 2,194,375
Weighted Average Exercise Price  
Balance Outstanding, Beginning | $ / shares
Granted | $ / shares 0.10
Cancelled | $ / shares
Balance Outstanding, Ending | $ / shares 0.10
Exercisable | $ / shares $ 0.10
Weighted Average Remaining Contractual Term (Years)  
Balance Outstanding, Ending 4 years 5 months 12 days
Exercisable 4 years 5 months 12 days
Aggregate Intrinsic Value  
Balance Outstanding, Ending | $ $ 6,000
Exercisable | $ $ 6,000